Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity.

MLA

Ye, Danyu, et al. “Inhibition of Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells by Ribavirin: Implication for Its Cardiac Developmental Toxicity.” Toxicology, vol. 435, Apr. 2020, p. 152422. EBSCOhost, https://doi.org/10.1016/j.tox.2020.152422.

APA

Ye, D., Bao, Z., Yu, Y., Han, Z., Yu, Y., Xu, Z., Ma, W., Yuan, Y., Zhang, L., Xu, Y., Ma, T., Liu, S., Gao, X., Yan, G., Huang, Q., Wang, X., Hua, B., Yang, F., Li, Y., & Cai, B. (2020). Inhibition of cardiomyocyte differentiation of human induced pluripotent stem cells by Ribavirin: Implication for its cardiac developmental toxicity. Toxicology, 435, 152422. https://doi.org/10.1016/j.tox.2020.152422

Chicago

Ye, Danyu, Zhengyi Bao, Yang Yu, Zhenbo Han, Ying Yu, Zihang Xu, Wenya Ma, et al. 2020. “Inhibition of Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells by Ribavirin: Implication for Its Cardiac Developmental Toxicity.” Toxicology 435 (April): 152422. doi:10.1016/j.tox.2020.152422.